Amos Gaikwad

2.3k citations
49 papers · 1.6k indexed · h-index 20
Topics
Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers)Acute Myeloid Leukemia Research (9 papers)Eosinophilic Disorders and Syndromes (7 papers)
Partner nations
United StatesIndiaItaly

In The Last Decade

Amos Gaikwad

48 papers receiving 1.6k citations

Peers

Amos Gaikwad
Comparison fields: 5 of 111
  • Molecular Biology 781
  • Genetics 282
  • Hematology 280
  • Oncology 277
  • Physiology 259
Replace Yi‐Chang Liu with:
Yi‐Chang Liu Taiwan
Tomoya Takeda Japan
Jakub Rohlena Czechia
Sutapa Ray United States
Isrid Sturm Germany
Weimin Fan China
Marina Bayeva United States
Yingjie Guan China
Wenhong Fan United States
Masaki Hiramoto Japan
Amos Gaikwad relative to Yi‐Chang Liu Taiwan Yi‐Chang Liu's profile →
Citations per field
00.5×1.5×2.0×
Yi‐Chang Liu · 1×
Citations per year

Countries citing papers authored by Amos Gaikwad

Since Specialization
Citations

This map shows the geographic impact of Amos Gaikwad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amos Gaikwad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amos Gaikwad more than expected).

Fields of papers citing papers by Amos Gaikwad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amos Gaikwad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amos Gaikwad. The network helps show where Amos Gaikwad may publish in the future.

Co-authorship network of co-authors of Amos Gaikwad

This figure shows the co-authorship network connecting the top 25 collaborators of Amos Gaikwad. A scholar is included among the top collaborators of Amos Gaikwad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amos Gaikwad. Amos Gaikwad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 8
4 1
5 1
6 22
7 38
8 42
9 88
10 10
11 11
12 32
13 151
14 65
15 69
16 37
17 9
18 172
19 36
20 10

About Amos Gaikwad

Amos Gaikwad is a scholar working on Hematology, Genetics and Toxicology, having authored 49 papers that have together received 1.6k indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers), Acute Myeloid Leukemia Research (9 papers) and Eosinophilic Disorders and Syndromes (7 papers). The work is most often cited by research in Toxicology (116 citations), Genetics (282 citations) and Hematology (280 citations). Amos Gaikwad has collaborated with scholars based in United States, India and Italy. Frequent co-authors include Delwin J. Long, Anil K. Jaiswal, Janet L. Stringer, Josef T. Prchal, Jordan U. Gutterman, Roberto Nussenzveig, Srđan Verstovšek, Valsala Haridas, Enli Liu and Roberto Barrios. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026